Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome

J Invest Dermatol. 2018 Oct;138(10):2286-2288. doi: 10.1016/j.jid.2018.03.1519. Epub 2018 Mar 30.

Authors

Tomonori Oka¹, Tomomitsu Miyagaki², Naomi Takahashi¹, Rina Nakajima¹, Hiroaki Kamijo¹, Hiraku Suga¹, Yoshihide Asano¹, Makoto Sugaya³, Shinichi Sato¹

Affiliations

¹ Department of Dermatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
² Department of Dermatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan. Electronic address: asahikari1979@gmail.com.
³ Department of Dermatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan; Department of Dermatology, International University of Health and Welfare, Chiba, Japan.

PMID: 29605670
DOI: 10.1016/j.jid.2018.03.1519

No abstract available

Publication types

Letter

MeSH terms

Adult
Biomarkers, Tumor / blood
CD48 Antigen / blood*
Female
Humans
Male
Middle Aged
Mycosis Fungoides / blood*
Mycosis Fungoides / pathology
Neoplasm Staging
Prognosis
Sezary Syndrome / blood*
Sezary Syndrome / pathology
Skin Neoplasms / blood*

Substances

Biomarkers, Tumor
CD48 Antigen
CD48 protein, human